Animal models have become indispensable in the search for novel strategies and therapeutics for effective therapies for neonatal encephalopathy (NE). Over the last 3 decades, the translation of ideas and questions from bedside to bench moved therapeutic hypothermia into the clinic as the first safe and effective therapy for NE.
use of animal models in the study of perinatal hypoxia-ischaemia has a history of over 200 years; studies initially showed that the premature animal is more tolerant of asphyxia than a term animal which is in turn more resistant to asphyxia than an adult (2, 3). In the 1950s-1970s, studies in the primate model showed that the pattern of brain injury was clearly influenced by the severity and type of hypoxia-ischaemia; these studies led to a description of two patterns of injury, namely: acute total asphyxia (4) and chronic partial asphyxia (5). In the last 30 years progress was made by using animal models of NE to understand the timing of the evolution brain injury after hypoxia-ischaemia. The translation of ideas and questions from bedside to bench moved therapeutic hypothermia into the clinic as the first safe and effective therapy for NE (6) (Fig 1) . Triggered by the observation in human babies that brain energy metabolism on phosphorus-31 ( 31 P) magnetic resonance spectroscopy (MRS) transiently recovered after birth and declined in the hours and days after birth despite intensive care support (7), studies in the newborn piglet (8) and rat (9) allowed pathophysiology and timing of events after hypoxia-ischaemia to be studied more precisely than in the human fetus and neonate. The concept that a therapy started after the injury changed the trajectory of brain damage was established.
Factors to consider for translation of animal studies to humans
There has been recent criticism of animal research (10) because of overoptimistic conclusions and inadequate control of bias especially in relation to compounds which, in reality, have little or no therapeutic potential. There are calls for more systematic reviews of animal studies and higher standards of research conduct and reporting (10). Dobbing and Sands used rates of brain growth to make cross species comparisons and provided the foundation for the use of animal models to study 
Non-Human Primate
Ranck and Windle (4) and Myers (5) developed the monkey models of NE in the 1950s to 1970s. Acute total asphyxia was induced at term by detaching the placenta at hysterotomy. Eleven to 16 minutes later the fetuses were delivered from their membranes and resuscitated (4). The pattern of injury was very similar to that seen in infants with a basal ganglia and thalamus injury following a sentinel event (19). In the partial asphyxia model, intrauterine asphyxia was produced in the pregnant term monkey by breathing halothane to cause maternal hypotension. Each fetus was exposed to asphyxia for 1-5 hours and then delivered and resuscitated and ventilated for 2 days. The pattern of injury was parasagittal, affecting the watershed areas (5).
A primate model is currently used in neonatal neuroprotection research where cord occlusion is for 15-18 minutes with extended MRI, MRS and neurodevelopmental follow-up to 9 months (20).
Piglet
Pigs are a suitable non-primate models of NE due to their relatively large size and anatomical similarities to man. Unlike rodents, their brain size more closely reflects the white/gray matter ratio seen in humans and is at comparatively similar developmental age at term (21). Pigs express similar metabolic changes as seen with MRS in asphyxiated infants. At UCL we use bilateral carotid artery occlusion in combination with hypoxia over 25 minutes to assess efficacy and safety of neuroprotective interventions (22-24). We quantify the hypoxic-ischaemic insult using well as in combination. Studies in small animal models will be required to define optimal combinations and timing of therapies before moving down the pathway of more complex animal models prior to human studies. The sensitising role of infection and inflammation is recognised as an important factor and specific neuroprotective agents may be needed to maximise protection. The "neuroprotection Holy Grail" may lie in uncovering these different disease phenotypes and employing a combination of therapeutic strategies to maximise clinical benefit. The piglet is ventilated with a nitrogen / air mix (4-6% oxygen) for 45 minutes. The degree of hypoxia is titrated to physiological parameters and fall in cytochrome activity on NIRS. EEG recordings are taken continuously and the HI insult is quantified by the duration of time the EEG flattens below 7 microvolts. 31P MRS during this period of time demonstrates the reduction in high-energy phosphate activity and increase in inorganic phosphate.
C o n f i d e n t i a l : F o r R e v i e w O n l y
The piglet is managed in an intensive care environment for a further 48 hours and treated for complications of HIE (eg. hypotension, seizures, hyperkalemia). The progress of the piglet is monitored by continuous EEG and serial MR scans at 24 and 48 hours following the sentinel event.
After 48 hours, the piglet is euthanised and undergoes a post-mortem. The internal organs are visually inspected for signs of hypoxia-ischaemia. The brain is fixed and dissected for histological examination to determine the extent of neuronal injury at specific regions of interest. 
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The piglet is anaesthetised with isofluorane via a facemask with monitoring of oxygen saturations. Isoflurance inhlataion and fentanyl infusion are continued throughout the study and the piglet is insentient throughout. A tracheostomy is sited and the piglet is connected to a ventilator. An umbilical arterial catheter is inserted for blood sampling and central arterial BP monitoring and an umbilical venous catheter for fluid and drug administration. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
